Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance.
The Impact of Medicaid Expansion on Stage at Diagnosis of Melanoma Patients: A Retrospective Study.
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit.
Emerging biomarkers and molecular targets for precision medicine in cervical cancer.
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer. Cureus. 2016 Feb 26; 8(2):e513.
View in:
PubMed
authors with profiles
Ravi Salgia
Randy Sweis